Elsevier

Lung Cancer

Volume 124, October 2018, Pages 160-167
Lung Cancer

Lung cancer CT screening: Psychological responses in the presence and absence of pulmonary nodules

https://doi.org/10.1016/j.lungcan.2018.08.001Get rights and content

Highlights

  • Pulmonary nodules are commonly found on CT scans screening for lung cancer (LC).

  • Some non-UK studies show negative psychological impacts of pulmonary nodule diagnosis.

  • We explored psychological impacts of nodule diagnosis during LC screening in the UK.

  • There was little impact on affect, health anxiety, worry, illness perception or risk perception.

  • There were fewer short-term avoidance symptoms in those diagnosed with nodules.

Abstract

Objectives

To determine the psychological response (thoughts, perceptions and affect) to a diagnosis of pulmonary nodules following a novel antibody blood test and computed tomography (CT) scans within a UK population.

Materials and methods

This study was nested within a randomised controlled trial of a blood test (Early CDT®-Lung test), followed by a chest x-ray and serial CT-scanning of those with a positive blood test for early detection of lung cancer (ECLS Study). Trial participants with a positive Early CDT®-Lung test were invited to participate (n = 338) and those agreeing completed questionnaires assessing psychological outcomes at 1, 3 and 6 months following trial recruitment. Responses of individuals with pulmonary nodules on their first CT scan were compared to those without (classified as normal CT) at 3 and 6 months follow-up using random effects regression models to account for multiple observations per participant, with loge transformation of data where modelling assumptions were not met.

Results

There were no statistically significant differences between the nodule and normal CT groups in affect, lung cancer worry, health anxiety, illness perceptions, lung cancer risk perception or intrusive thoughts at 3 or 6 months post-recruitment. The nodule group had statistically significantly fewer avoidance symptoms compared to the normal CT group at 3 months (impact of events scale avoidance (IES-A) difference between means −1.99, 95%CI −4.18, 0.21) than at 6 months (IES-A difference between means 0.88, 95%CI −1.32, 3.08; p-value for change over time = 0.003) with similar findings using loge transformed data.

Conclusion

A diagnosis of pulmonary nodules following an Early CDT®-Lung test and CT scan did not appear to result in adverse psychological responses compared to those with a normal CT scan.

Introduction

Lung cancer is the most commoncause of cancer-related deaths worldwide. [1] During 2014 approximately 46,400 individuals in the United Kingdom (UK) were diagnosed with lung cancer [2]. Despite the incidence of lung cancer decreasing [3], mortality rates remain high, with 1-year survival rates ranging from 71% when diagnosed at stage 1 to 16% at stage 4 [4].

The National Lung Screening Trial (NLST), showed serial computed tomography (CT) scanning was associated with a 20% reduction in lung cancer mortality. [5] However, screening has potential harms, such as radiation exposure, the detection of non-clinically relevant findings, over-diagnosis and psychosocial harms [[6], [7], [8], [9], [10], [11]]. It is therefore important to ensure acceptability to the population being screened [12], and that overall benefits outweigh the harms [13].

Assessments of the psychosocial impact of lung cancer screening are limited to studies using CT scanning. The NLST, Pittsburgh Lung Screening Study, and the UK Lung Cancer Screening (UKLS) Trial found increased anxiety in those with true positive screening results compared to those with negative results. The UKLS also found significantly higher cancer worry scale scores 2 weeks after receiving CT scan results in those referred for a repeat CT scan compared to those with negative results. However, absolute differences were small and not thought to be clinically important. [[14], [15], [16], [17]] Additionally, the Dutch-Belgian Randomized Lung Cancer Screening Trial (NELSON trial) and the Pittsburgh Lung Screening Study found increased lung cancer specific distress in those with an indeterminate result, which diminished over time [16,18,19].

As screening with CT scanning becomes more widespread, more people will be found to have incidental findings, such as pulmonary nodules. Pulmonary nodules are widely defined as round lesions within the lung, less than 3 cm in diameter and surrounded by normal lung tissue. [20,21] The NLST reported an incidence of pulmonary nodules of 25.9% in participants with a pack year history of at least 30 years [5]. Several studies used psychological measures to assess the negative impact of a diagnosis of pulmonary nodules [[22], [23], [24], [25]], finding increased emotional distress [22,23], frustration and fear [25] amongst those with nodules. Additionally, French individuals diagnosed with pulmonary nodules reported lower health-related quality of life (HRQoL) (measured using the SF36) compared to the French general population. [24]

Our study assesses short and mediumterm psychological responses amongst a sample of participants, with or without pulmonary nodule(s) identified on their first CT scan, within the Early Cancer Detection TestLung Cancer Scotland Study (ECLS Study). [26] This is a randomised controlled trial assessing the effectiveness of a blood test for lung cancer screening, measuring autoantibodies against seven antigens (Early CDT®-Lung test) [26,27]. A positive Early CDT®-Lung test is associated with a significantly increased risk of malignancy in the presence of pulmonary nodules 420 mm in diameter [28], and the consequent potential for adverse psychological effects. This study is therefore timely in assessing psychological impacts of this test and subsequent CT scanning.

Section snippets

Methods

This paper presents data on a sub-sample of participants in the ECLS study. Current or ex-smokers aged 50–75 years, with at least 20 pack-years, or fewer pack-years with a first-degree relative with lung cancer from Greater Glasgow and Clyde or Tayside, were randomised 1:1 to an Early CDT®-Lung test group or a non-screened control group. All trial participants were asked to complete a baseline questionnaire preceding awareness of group allocation. Those with positive Early CDT®-Lung tests were

Results

Three hundred and thirty eight Early CDT®-Lung test-positive ECLS trial participants took part in the psychological outcomes study, 269 (174 in the normal CT group and 95 in the nodule group) of whom were eligible to be included in the analyses presented in this paper (Fig. 1). Response rates to follow-up questionnaires were high. The analysis included 95% at 3 months and 94% at 6 months. All participants were aware of their CT scan result on completing the 3-month questionnaire.

Summary

This study demonstrates that a diagnosis of pulmonary nodules on a CT scan following an Early CDT®-Lung positive result for lung cancer screening does not result in an adverse psychological response in relation to affect, health anxiety, thought intrusion and illness perception compared to those who had a normal CT scan in both the short and medium-term. Although those in the nodule group had statistically significantly fewer avoidance behaviours than those in the normal CT group at 3 months

Funding

This study was carried out as part of a National Institute for Health Research (NIHR) School for Primary Care Research (SPCR) funded academic clinical fellowship. The views expressed are those of the author(s) and not necessarily those of the NIHR, the NHS or the Department of Health. The ECLS study was funded by the Scottish Executive and Oncimmune Ltd. The follow-up data collection was funded by University of Nottingham PhD studentships and by Oncimmune Ltd.

Ethical approval

Ethical approval was given by the East of Scotland Research Ethics Service as an amendment to the main ECLS study: REC reference 13/ES/0024, amendment number AM16.

Competing interests

The University of Dundee received funding from the Scottish Executive, the University of Glasgow received funding from the Scottish Executive and Oncimmune Ltd and the University of Nottingham received funding from Oncimmune Ltd to conduct this research. Marcia Clark was funded by an NIHR School for Primary Care Research Academic Clinical Fellowship and Laura Bedford and Ben Young were funded by University of Nottingham PhD studentships.

John Robertson reports grants from AstraZeneca, personal

Acknowledgements

We thank the ECLS trial staff for recruiting participants and collecting baseline data from the trial participants. We gratefully acknowledge the contribution to this study and publication made by the Tayside Clinical Trials Unit (TCTU).

References (37)

  • R.P. Harris et al.

    The harms of screening: a proposed taxonomy and application to lung cancer screening

    JAMA Intern. Med.

    (2014)
  • P. Nanavaty et al.

    Lung cancer screening: advantages, controversies, and applications

    Cancer Control

    (2014)
  • P.F. Pinsky

    Assessing the benefits and harms of low-dose computed tomography screening for lung cancer

    Lung Cancer Manag.

    (2014)
  • J.M.G. Wilson et al.

    Principles and Practice of Screening for Disease

    (1968)
  • I.F. Gareen et al.

    Impact of lung cancer screening results on participant health-related quality of life and state anxiety in the National Lung Screening Trial

    Cancer

    (2014)
  • J.K. Field et al.

    The UK Lung Cancer Screening Trial: a pilot randomised controlled trial of low-dose computed tomography screening for the early detection of lung cancer

    Health Technol. Assess.

    (2016)
  • M.M. Byrne et al.

    Anxiety, fear of cancer, and perceived risk of cancer following lung cancer screening

    Med. Decis. Making

    (2008)
  • K. Brain et al.

    Long-term psychosocial outcomes of low-dose CT screening: results of the UK Lung Cancer Screening randomised controlled trial

    Thorax

    (2016)
  • Cited by (12)

    View all citing articles on Scopus
    View full text